Valion Bio (VBIO) Accumulated Expenses (2021 - 2025)
Valion Bio (VBIO) posted quarterly Accumulated Expenses of $194000.0 for Q2 2025, up 177.14% year-over-year from $70000.0 in Q2 2024, and up 385.0% quarter-over-quarter from $40000.0 in Q3 2024.
Valion Bio (VBIO) Accumulated Expenses (2021 - 2025) Analysis & Trends
Valion Bio's Accumulated Expenses history runs 5 years deep, the most recent figure standing at $194000.0 for Q2 2025.
- In Q2 2025, Accumulated Expenses rose 177.14% year-over-year to $194000.0; the TTM figure through Jun 2025 stood at $194000.0 (up 177.14% YoY), while the FY2023 annual figure was $218000.0, up 50.34% from the prior year.
- Accumulated Expenses for Q2 2025 stood at $194000.0, up from $40000.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $218000.0 in Q4 2023, with the low at $40000.0 in Q3 2024.
- The 5-year median for Accumulated Expenses is $145000.0 (2022), against an average of $139000.0.
- The sharpest annual moves came in 2022 and 2025: Accumulated Expenses retreated 29.61% in 2022, then soared 177.14% in 2025.
- Valion Bio's Accumulated Expenses stood at $206000.0 in 2021, then declined by 29.61% to $145000.0 in 2022, then jumped by 50.34% to $218000.0 in 2023, then sank by 81.65% to $40000.0 in 2024, then jumped by 385.0% to $194000.0 in 2025.
- Business Quant data shows VBIO's Accumulated Expenses at $194000.0 in Q2 2025, $40000.0 in Q3 2024, and $70000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Valion Bio | 405,599.63 | -1.79 Mn | -45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 194,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 218,000.00 |
| Dec 31, 2022 | 145,000.00 |
| Dec 31, 2021 | 206,000.00 |